Home > PE Ratio > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
PE (Price/Earnings) Ratio

The Current P/E Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is -7.42.

Share Price ₹29.7Apr 19,2024
Market Cap ₹128.2 Cr
Earnings-TTM₹-17.3 CrTTM-Standalone Results
Price/Earnings-7.42xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is calculated as :

Current Market Cap [ ₹128.2 Cr] as on Apr 19,2024

(/) Earnings [ ₹-17.3 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ -7.42x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION , the investors are currently willing to pay -7.42 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION over the last five years.

Historical PE (Price/Earnings) ratio chart of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION


PE Ratio Performance Analysis for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's latest p/e ratio is -7.42x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.00x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio peaked in Mar2023 at 0x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION -17.27-7.42128.2
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.60365,311.0
CIPLA LTD3,744.0329.01108,623.0
DR REDDYS LABORATORIES LTD5,209.4019.0399,134.3
ZYDUS LIFESCIENCES LTD2,954.2031.4192,794.9
DIVIS LABORATORIES LTD1,382.9770.4397,408.4
MANKIND PHARMA LTD1,743.3053.6793,565.4
TORRENT PHARMACEUTICALS LTD1,494.0057.4785,858.5
LUPIN LTD1,809.7438.9670,506.8
AUROBINDO PHARMA LTD2,777.8922.9363,697.4
ABBOTT INDIA LTD1,145.5848.4755,528.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -7.42x
Max industry PE 70.43x
Median industry PE 38.96x
Average industry PE 36.78x



You may also like the below Video Courses